EyePoint Pharmaceuticals Inc
EYPT
Market Cap$579.39M
Close$
$-5.79
155.9% downside
Current Fair Value
155.9% downsideOvervalued by 155.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $579.39 Million |
|---|---|
| Enterprise Value | $523.43 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.32 |
| Beta | 1.64 |
| Outstanding Shares | 69,767,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4 |
|---|---|
| PEG | -7.37 |
| Price to Sales | - |
| Price to Book Ratio | 2.59 |
| Enterprise Value to Revenue | 9.34 |
| Enterprise Value to EBIT | -3.32 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data